Uncategorised - European Medical Journal

Continue
4 Mins
28th April 2020

Keeping Frankenstein’s Monster at Bay

I am not a fatalist, I do not believe things happen for a reason, but I do believe we can find reason in the things that happen…
11 Mins
27th April 2020

Editor's Pick: Targeting Raised von Willebrand Factor Levels in Liver Diseases: Opening Up Newer Therapeutic Avenues

The most commonly inherited bleeding disorder, von Willebrand disease, is caused by the deficiency of von Willebrand factor (VWF)…
Cancer Care Seeing Dramatic Changes in Light of COVID-19
1 Mins
26th April 2020

Cancer Care Seeing Dramatic Changes in Light of COVID-19

SIGNIFICANT changes in cancer care are occurring and expected to continue for the duration of the COVID-19 pandemic, a message delivered in a recently…
Age and sex
1 Mins
26th April 2020

Age and Sex Shown to Not Influence Overall Survival in Metastatic Renal Cell Carcinoma

PATIENT counselling is more important than ever for those with cancer, especially considering the burgeoning number of treatments available…
24th April 2020

ICDS Interview with Professor Abe Fingerhut

We sat down with Prof Abe Fingerhut at the ICDS to discuss his long and illustrious career in colorectal surgery.
24th April 2020

EMJ Podcast: The Frontline of Coronavirus

In this special episode, a chat with an NHS doctor on the frontline of COVID-19 and a patient who has just recovered from the virus.
4 Mins
23rd April 2020

In Vitro Fertilisation and Covid-19: Insights From An Embryologist

We interviewed clinical embryologist Prof George Anifandis, who discussed some of the key advances and challenges in reproductive medicine and delineated…
AACR Virtual Annual Meeting I
23rd April 2020

AACR Virtual Annual Meeting I

The AACR Virtual Annual Meeting I will take place April 27-28. This meeting, which will be the first of two virtual meetings, is FREE and will feature an…

Talking to Pierre van Weperen

Pierre van Weperen, Chief Commercial Officer, Grow Biotech, discusses the potential of medicinal cannabis and big pharma vs start-ups.

Does pharma need more 'social' leaders?

Pharmaceutical companies have embraced the corporate social media account, but many lack the personal touch of a profile run by their leader. The opportunity to connect with employees and patients alike is unbounded; the time to log on is now.